SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Formerly About Advanced Micro Devices
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
Recommended by:
pocotrader
To: h_ who wrote (1341236)2/4/2022 8:10:36 PM
From: Tenchusatsu1 Recommendation  Read Replies (3) of 1571868
 
Thanks for the link, H. I scrolled down to page 9 before I saw first evidence of bullshit.

It assumes that Phase III trials were supposed to last for three years, then builds up an argument for "early unblinding of randomized control trial" based on that assumption.

But the assumption is false. Pfizer was not required to conduct a three-year study before getting approval. That was never the standard. Instead, the trial started in July of 2020 and concluded after three months.

Those results have been published, and numerous scientists peer-reviewed it, both within and outside the FDA. It's a matter of public record, so it's no secret how long the Phase III trial took.

Yet the "report" that you linked to flat out lies about how long the Phase III trial should have lasted.

I didn't read the rest of your "report," because I can already tell just how much the authors are willing to twist the truth.

Tenchusatsu
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News